Prognostic implications of bundle branch block in patients undergoing primary coronary angioplasty in the stent era

David Vivas1, María Jose Pérez-Vizcayno, Rosana Hernández-Antolín

  • 1Cardiovascular Institute, San Carlos University Hospital, Madrid, Spain. dvivas@secardiologia.es

Insights

Bundle branch block (BBB) in ST-elevation myocardial infarction patients undergoing primary angioplasty indicates a poor prognosis. Persistent BBB, particularly, is an independent predictor of death and reinfarction, highlighting its significance.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Electrocardiography

Background:

  • Bundle branch block (BBB) presence in ST-segment elevation myocardial infarction (STEMI) is linked to adverse outcomes.
  • Prognostic implications of BBB in the stent era and specific BBB types (right vs. left, previous vs. transient/persistent) require clarification.

Purpose of the Study:

  • To investigate the prognostic significance of bundle branch block (BBB) in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary angioplasty.
  • To differentiate the impact of various BBB types (right vs. left, previous vs. transient vs. persistent) on patient outcomes.

Main Methods:

  • Analysis of data from 913 consecutive STEMI patients treated with primary angioplasty.
  • Prospective collection of clinical, electrocardiographic, and angiographic data.
  • Median follow-up of 19 months, with death and reinfarction as the primary endpoint.

Main Results:

  • Bundle branch block (BBB) was present in 15% of patients, associated with older age, diabetes, anterior infarctions, higher Killip class, and lower ejection fraction.
  • Patients with BBB exhibited significantly greater mortality.
  • Persistent RBBB/LBBB independently predicted death and reinfarction, with higher event rates compared to previous or transient BBB.

Conclusions:

  • Bundle branch block (BBB) in STEMI patients undergoing primary angioplasty is associated with poor short- and long-term prognosis.
  • Persistent BBB represents a particularly high-risk subgroup, independent of other factors.
  • These findings underscore the importance of identifying and monitoring BBB in STEMI patients treated with primary angioplasty.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...